Release Details

image description

Celestica Announces Date for Fourth Quarter 2021 Financial Results

Jan 12, 22 at 6:16 PM EST

TORONTO, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Celestica Inc. (NYSE: CLS) (TSX: CLS), a leader in design, manufacturing and supply chain solutions for the world's most innovative companies, will host its fourth quarter 2021 financial results, webcast and conference call on January 27, 2022. Financial results will be released after market close on January 26, 2022.

Event: Fourth Quarter 2021 Financial Results, Webcast and Conference Call
Date: January 27, 2022
Time: 8:00 am EST
Weblink: Webcast details can be found on the Investor Relations portal at www.celestica.com.

An audio replay of the webcast will be available on our website after completion of the call.

About Celestica
Celestica enables the world's best brands. Through our recognized customer-centric approach, we partner with leading companies in Aerospace and Defense, Communications, Enterprise, HealthTech, Industrial, Capital Equipment, and Energy to deliver solutions for their most complex challenges. As a leader in design, manufacturing, hardware platform and supply chain solutions, Celestica brings global expertise and insight at every stage of product development - from the drawing board to full-scale production and after-market services. With talented teams across North America, Europe and Asia, we imagine, develop and deliver a better future with our customers.

For more information, visit www.celestica.com.

Our securities filings can also be accessed at www.sedar.com and www.sec.gov.


Contact: Celestica Investor Relations (416) 448-2211 clsir@celestica.com



The information that you are accessing on this website may include forward-looking statements related to our future growth, trends in our industry, our financial and operational results and performance that are based on current expectations, forecast and assumptions involving risk and uncertainties that could cause actual outcomes and results to differ materially.


Read the full Cautionary Note here